A Study in Healthy Men and Women to Test Whether BI 1569912 Influences the Amount of Repaglinide, Midazolam and Bupropion in the Blood

Conditions: Healthy Interventions: Drug: BI 1569912; Drug: repaglinide; Drug: midazolam; Drug: bupropion Sponsors: Boehringer Ingelheim Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials